<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-A19WRSUL</identifier><date>2017</date><creator>Jagrič, Timotej</creator><creator>Lešnik, Tomaž</creator><relation>documents/doc/A/URN_NBN_SI_doc-A19WRSUL_001.pdf</relation><relation>documents/doc/A/URN_NBN_SI_doc-A19WRSUL_001.txt</relation><format format_type="issue">4</format><format format_type="volume">63</format><format format_type="type">article</format><format format_type="extent">str. 17-28</format><identifier identifier_type="ISSN">0547-3101</identifier><identifier identifier_type="COBISSID">12962332</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-A19WRSUL</identifier><language>eng</language><publisher>Društvo ekonomistov Maribor</publisher><publisher>Ekonomski center Maribor</publisher><publisher>Ekonomsko-poslovna fakulteta</publisher><source>Naše gospodarstvo</source><rights>InC</rights><subject language_type_id="slv">davčni nadzor</subject><subject language_type_id="slv">davek na dodano vrednost</subject><subject language_type_id="slv">davki</subject><subject language_type_id="slv">inšpekcijski nadzor</subject><title>Audits as a vaccine or just Aspirin?</title></Record>